Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimum Effective Dose of Intrathecal Ropivacaine Required for Cesarean Delivery: A Prospective, Randomized Comparison Between L2-3 and L3-4 Approach

NCT02565303 is registered in ClinicalTrials.gov with Shanghai 6th People's Hospital as lead sponsor.

NCT NCT02565303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02565303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimum Effective Dose of Intrathecal Ropivacaine Required for Cesarean Delivery: A Prospective, Randomized Comparison Between L2-3 and L3-4 Approach
Lead sponsor
Shanghai 6th People's Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2015
Completion date
June 30, 2017
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinal anesthesia